Literature DB >> 9171874

Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.

M L López-Rodríguez1, M L Rosado, B Benhamú, M J Morcillo, E Fernández, K J Schaper.   

Abstract

A series of 48 bicyclohydantoin-phenylpiperazines (1-4) with affinity for 5-HT1A and alpha 1 receptors was subjected to three-dimensional quantitative structure-affinity relationship analysis using comparative molecular field analysis (CoMFA), in order to get insight into the structural requirements that are responsible for 5-HT1A/alpha 1 selectivity. Good models (high cross-validation correlations and predictive power) were obtained for 5-HT1A and alpha 1 receptors. The resulting 3D-QSAR models rationalize steric and electrostatic factors which modulate binding to 5-HT1A and alpha 1 receptors. A comparison of these models gives an additional understanding for 5-HT1A/alpha 1 selectivity: (a) Substitution at the ortho position by a group with negative potential is favorable to affinity for both receptors. (b) The meta position seems to be implicated in 5-HT1A/alpha 1 selectivity. While the 5-HT1A receptor is able to accommodate bulky substituents in the region of its active site, the steric requirements of the alpha 1 receptor are more restricted (optimum volume of substituent 11-25 A3). (c) For both receptors the para position represents a region where the volume accessible by the ligands is limited. (d) The hydantoin moiety and the side chain length seem to modulate not only the affinity but also 5-HT1A/alpha 1 selectivity. The 3D-QSAR models reveal an useful predictive information for the design of new selective ligands.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171874     DOI: 10.1021/jm960744g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Quantitative prediction of antitarget interaction profiles for chemical compounds.

Authors:  Alexey V Zakharov; Alexey A Lagunin; Dmitry A Filimonov; Vladimir V Poroikov
Journal:  Chem Res Toxicol       Date:  2012-11-02       Impact factor: 3.739

2.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  Development of Fluorescent Ligands for the Human 5-HT1A Receptor.

Authors:  Dulce Alonso; Henar Vázquez-Villa; Ana M Gamo; María F Martínez-Esperón; Mariola Tortosa; Alma Viso; Roberto Fernández de la Pradilla; Elena Junquera; Emilio Aicart; Mar Martín-Fontecha; Bellinda Benhamú; María L López-Rodríguez; Silvia Ortega-Gutiérrez
Journal:  ACS Med Chem Lett       Date:  2010-05-14       Impact factor: 4.345

4.  Influence of Open Chain and Cyclic Structure of Peptidomimetics on Antibacterial Activity in E. coli Strains.

Authors:  Parul Sahrawat; Paweł Kowalczyk; Dominik Koszelewski; Mateusz Szymczak; Karol Kramkowski; Aleksandra Wypych; Ryszard Ostaszewski
Journal:  Molecules       Date:  2022-06-06       Impact factor: 4.927

Review 5.  An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs.

Authors:  Kenneth Lundstrom
Journal:  Methods Mol Biol       Date:  2009
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.